HALO (HALOZYME THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 9 institutional investors hold HALO (HALOZYME THERAPEUTICS INC) with a combined value of $1.11B across 134,264,045 shares. The largest holder is BlackRock, Inc. with a position worth $885.25M (0.01% of their portfolio). 6 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$1.11B
Total Shares Held
134,264,045
Institutional Holders
9
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $885.25M | 0.01% | +2.3% |
| 2 | Point72 Asset Management, L.P. | $54.24M | 0.06% | +41.1% |
| 3 | CITADEL ADVISORS LLC | $45.62M | 0.01% | +0.0% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $37.87M | 0.06% | -43.7% |
| 5 | Bridgewater Associates, LP | $37.79M | 0.14% | +15.3% |
| 6 | CITADEL ADVISORS LLC | $31.47M | 0.00% | +69.2% |
| 7 | Point72 Asset Management, L.P. | $8.12M | 0.01% | +50.0% |
| 8 | BlackRock, Inc. | $7.63M | 0.00% | -17.3% |
| 9 | CITADEL ADVISORS LLC | $2.42M | 0.00% | -89.3% |
Track HALO institutional moves
Get notified when hedge funds change their HALO positions.